Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous cell therapy for knee osteoarthritis
2010-022072-31Phase 2Unknown
- Sponsor
- The Robert Jones and Agnes Hunt Orthopaedic Hospital
- Start
- Jun 2011
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous cultured chondrocytes in knee osteoarthritis (OA), Knee Osteochondral Defect (OCD) and chondral knee defect (3 arms), sponsored by The Robert Jones and Agnes Hunt Orthopaedic Hospital. Primary endpoint: Lysholm Score. Status: unknown.
02
Drugs
autologous cultured chondrocytes
03
Conditions
knee osteoarthritis (OA)Knee Osteochondral Defect (OCD)chondral knee defect
Beyond the preview
Go deeper on 2010-022072-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022072-31.